Clinical Trials Browser

Mesothelioma, Malignant × Doxorubicin × Clear all

Mesothelioma, Malignant, Colonic Neoplasms, Fallopian Tube Neoplasms, Liposarcoma, Ovarian Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Rhabdomyosarcoma, Sarcoma, Stomach Neoplasms, Desmoplastic Small Round Cell Tumor

NCT00859495 2020-08-25

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Phase 2 Terminated

9 enrolled 4 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00634205 2015-02-12

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Phase 2 Completed

45 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT00024271 2014-01-06

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00003034 2013-11-06

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Phase 3 Unknown

300 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00020124 2012-03-15

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma

Clinical Trials

TOASTIT

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs